1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.52%
Revenue growth 15-20% – Very strong. Benjamin Graham might confirm that the growth is organic rather than fueled solely by acquisitions.
3.07%
Gross profit growth 0-5% – Limited. Howard Marks would question whether cost pressures or competition are capping margin gains.
-23.79%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-11.85%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
-39.97%
Negative net income growth shows profitability erosion. Benjamin Graham would worry about solvency and longer-term viability.
-40.07%
Negative EPS growth underscores deteriorating earnings per share. Benjamin Graham would worry about ongoing dilution or weakened profitability.
-40.07%
Negative diluted EPS growth suggests diluted shares grew or net income fell. Benjamin Graham would see this as a serious setback to shareholder value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
10Y revenue/share CAGR 4-7% – Moderate. Peter Lynch might look for potential catalysts to boost growth beyond mid-single digits.
70.25%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
51.85%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.55%
A negative 10Y net income/share CAGR reflects a decade of weakening profits. Benjamin Graham would be extremely cautious unless a turnaround is evident.
-95.82%
A negative 5Y net income/share CAGR reveals a mid-term deterioration in bottom-line earnings. Benjamin Graham would be cautious unless a credible turnaround is visible.
109.89%
3Y net income/share CAGR above 15% – Rapid short-term profit growth. Benjamin Graham would verify if it’s driven by core revenue or temporary cost reductions.
284.19%
10Y equity/share CAGR above 12% – Excellent long-term book value compounding. Warren Buffett would see if consistent profits plus moderate payouts drive this growth.
35.04%
5Y equity/share CAGR above 12% – Strong mid-term book value expansion. Warren Buffett would see if steady profits and moderate payout ratios sustain this pace.
26.04%
3Y equity/share CAGR above 12% – Excellent recent net worth expansion. Warren Buffett would check consistent earnings retention or beneficial buybacks driving this growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.25%
Receivables growth 0-10% – Typically normal if revenue grows at a similar pace. Seth Klarman verifies the AR-to-revenue ratio stays constant.
7.64%
Inventory growth 5-10% – Some buildup. Peter Lynch checks if it’s seasonal or due to new product lines and expects them to sell through.
1.58%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
-0.22%
Falling book value/share indicates net losses, large dividends, or intangible impairments. Benjamin Graham warns unless there’s a strategic reason.
4.58%
Debt rising up to 5% yoy – Mild increase. Peter Lynch sees expansions or acquisitions possibly justifying modest new debt.
1.28%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
-17.74%
Shrinking SG&A can raise profits short term, but might risk cutting key growth drivers. Benjamin Graham sees if this is sustainable.